Pseudomonas Aeruginosa Infection
📧 Sign up to get email alerts when something new happens for Pseudomonas Aeruginosa Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis [Phase 4]
Phase 4 trial evaluating inhaled tobramycin for eradication of Pseudomonas aeruginosa in adults with bronchiectasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia [Phase 1]
Phase 1 clinical trial MP101 for acute Pseudomonas aeruginosa pneumonia is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.
A completed clinical trial update for the SAMPAN study evaluating carbapenem-resistant Pseudomonas aeruginosa, including colonization and no…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation [Phase 4]
Phase 4 trial evaluating ceftolozane-tazobactam for directed treatment of Pseudomonas aeruginosa bacteremia and pneumonia in patients with h…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection [Phase 2]
This completed Phase 2 trial evaluated inhaled AP-PA02 for safety, phage kinetics, and efficacy in non-cystic fibrosis bronchiectasis with c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Animal-Assisted Visitation Program Chlorhexidine Trial [Phase 4]
Phase 4 clinical trial update on an animal-assisted visitation program using chlorhexidine, sponsored by Johns Hopkins Bloomberg School of P…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating nebulized bacteriophage therapy for chronic Pseudomonas aeruginosa lung infection in cystic fibrosis p…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa [Phase 2]
Phase 2 safety and efficacy study of Ftortiazinon for complicated urinary tract infections caused by Pseudomonas aeruginosa has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Clinical Study on the Treatment of Lower Respiratory Tract Infection With Pseudomonas Aeruginosa by Ceftazidime and Avibatam
A completed clinical study evaluating ceftazidime/avibactam for treating lower respiratory tract infections caused by Pseudomonas aeruginosa…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)
A completed clinical trial at CHRU Nancy evaluated Pseudomonas aeruginosa infections in ICU patients with COVID-19.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® [Phase 1, Phase 2]
Phase 1/2 clinical trial update for DUOFAG assessing safety and efficacy in various bacterial infections including surgical site and Staphyl…
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Targeted AntiBiotics for Chronic Pulmonary Diseases [Phase 4]
Phase 4 clinical trial update for targeted antibiotics in chronic pulmonary diseases has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Open Label Extension to Bridging Study CTBM100C2303 [Phase 3]
Open-label extension to a bridging Phase 3 study for Pseudomonas aeruginosa and cystic fibrosis was completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection [Phase 3]
Phase 3 extension study of liposomal amikacin for inhalation in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection compl…
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections [Phase 3]
A Phase 3 study evaluating Arikayce in cystic fibrosis patients with chronic Pseudomonas aeruginosa infections has completed with results po…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients [Phase 4]
Phase 4 trial evaluating population pharmacokinetics and safety of intravenous ceftolozane/tazobactam in adult cystic fibrosis patients, com…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin [Phase 3]
Phase 3 trial update reporting pharmacokinetic evaluation of an 8-week course of inhaled tobramycin for Pseudomonas aeruginosa infections.
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating anti-pseudomonas IgY to prevent infections in cystic fibrosis patients.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43 [Phase 2, Phase 3]
A confirmatory Phase II/III trial evaluating the IC43 vaccine for Pseudomonas aeruginosa infection has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies
Completed clinical trial comparing microbiological resistance and effects when alternating inhaled antibiotic therapies in cystic fibrosis p…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children [Phase 4]
Phase 4 clinical trial update reports population pharmacokinetics of prolonged-infusion meropenem in children with cystic fibrosis. The stud…
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa [Phase 3]
This document provides an update on a Phase 3 clinical trial comparing continuous versus intermittent infusion of Zosyn (piperacillin-tazoba…
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways [Phase 3]
Phase 3 safety results for AZLI in children with cystic fibrosis and chronic Pseudomonas aeruginosa infection have been posted. The trial is…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Cipro Inhaler for Cystic Fibrosis Children Ages 6-12 [Phase 1]
A Phase 1 clinical trial evaluating inhaled ciprofloxacin (Cipro Inhaler) in children with cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization [Phase 2]
Phase 2 trial evaluating sino-nasal inhaled colistin in cystic fibrosis patients with Pseudomonas aeruginosa colonization has completed.